Table 2.
Adverse events during the follow-up period (>10%).
Adverse Events | Any Grade (%) | Grade ≥ 3 (%) |
---|---|---|
Hypertension | 17 (42.5%) | 3 (7.5%) |
Proteinuria | 16 (40.0%) | 6 (15.0%) |
Edema | 15 (37.5%) | 1 (2.5%) |
Fever | 13 (32.5%) | - |
Fatigue | 11 (27.5%) | - |
Pruritus | 10 (25.0%) | - |
Decreased appetite | 7 (17.5%) | 1 (2.5%) |
Hand-foot skin reaction | 5 (12.5%) | - |
Nasal bleeding | 5 (12.5%) | 1 (2.5%) |
Rash | 4 (10.0%) | - |
Thyroid function abnormality | 4 (10.0%) | - |
Stomatitis | 4 (10.0%) | - |